"We have seen many different what one might call 'strains' of COVID-19," Azar told host Martha MacCallum. But Azar said the U.S. vaccines appear to be "spot-on target with the different strains." The U.S. began to roll out the Pfizer-BioNTech vaccine this week amid a troubling surge in cases. They are not getting used enough, and they are not getting used early enough in the course of the disease," he said. The Eli Lilly monoclonal antibodies are free, Azar said, but doctors have not been prescribing the treatment as often as they should.

Source: Fox News December 16, 2020 02:37 UTC